Thrombozytenaggregationshemmer
- 19 December 2012
- journal article
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 124 (S2) , 31-32
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled TrialJAMA, 2008
- The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseBMJ, 2008
- Aspirin for the Primary Prevention of Cardiovascular Events in Women and MenJAMA, 2006
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002